Editas Medicine Inc Stock, NASDAQ:EDIT
11 Hurley Street, 11 Hurley Street, Cambridge, Massachusetts 02141
United States of America
Number of Employees: 235
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.